Your browser doesn't support javascript.
loading
Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age.
Sutphen, Courtney L; Jasielec, Mateusz S; Shah, Aarti R; Macy, Elizabeth M; Xiong, Chengjie; Vlassenko, Andrei G; Benzinger, Tammie L S; Stoops, Erik E J; Vanderstichele, Hugo M J; Brix, Britta; Darby, Heather D; Vandijck, Manu L J; Ladenson, Jack H; Morris, John C; Holtzman, David M; Fagan, Anne M.
Affiliation
  • Sutphen CL; Knight Alzheimer's Disease Research Center, Washington University, St Louis, Missouri2Department of Neurology, Washington University, St Louis, Missouri3Hope Center for Neurodegenerative Disorders, Washington University, St Louis, Missouri.
  • Jasielec MS; Knight Alzheimer's Disease Research Center, Washington University, St Louis, Missouri4Division of Biostatistics, Washington University, St Louis, Missouri.
  • Shah AR; Knight Alzheimer's Disease Research Center, Washington University, St Louis, Missouri2Department of Neurology, Washington University, St Louis, Missouri3Hope Center for Neurodegenerative Disorders, Washington University, St Louis, Missouri.
  • Macy EM; Department of Pathology and Immunology, Washington University, St Louis, Missouri.
  • Xiong C; Knight Alzheimer's Disease Research Center, Washington University, St Louis, Missouri4Division of Biostatistics, Washington University, St Louis, Missouri.
  • Vlassenko AG; Knight Alzheimer's Disease Research Center, Washington University, St Louis, Missouri6Department of Radiology, Washington University, St Louis, Missouri.
  • Benzinger TL; Knight Alzheimer's Disease Research Center, Washington University, St Louis, Missouri6Department of Radiology, Washington University, St Louis, Missouri.
  • Stoops EE; ADx NeuroSciences, Ghent, Belgium.
  • Vanderstichele HM; ADx NeuroSciences, Ghent, Belgium.
  • Brix B; EUROIMMUN, Lübeck, Germany.
  • Darby HD; Fujirebio US, Malvern, Pennsylvania.
  • Vandijck ML; Fujirebio Europe, Ghent, Belgium.
  • Ladenson JH; Department of Pathology and Immunology, Washington University, St Louis, Missouri.
  • Morris JC; Knight Alzheimer's Disease Research Center, Washington University, St Louis, Missouri2Department of Neurology, Washington University, St Louis, Missouri3Hope Center for Neurodegenerative Disorders, Washington University, St Louis, Missouri.
  • Holtzman DM; Knight Alzheimer's Disease Research Center, Washington University, St Louis, Missouri2Department of Neurology, Washington University, St Louis, Missouri3Hope Center for Neurodegenerative Disorders, Washington University, St Louis, Missouri.
  • Fagan AM; Knight Alzheimer's Disease Research Center, Washington University, St Louis, Missouri2Department of Neurology, Washington University, St Louis, Missouri3Hope Center for Neurodegenerative Disorders, Washington University, St Louis, Missouri.
JAMA Neurol ; 72(9): 1029-42, 2015 Sep.
Article in En | MEDLINE | ID: mdl-26147946
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers / Asymptomatic Diseases / Alzheimer Disease Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: JAMA Neurol Year: 2015 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers / Asymptomatic Diseases / Alzheimer Disease Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: JAMA Neurol Year: 2015 Document type: Article